Whoop Refuses to Pull Blood Pressure Tool After FDA Warning (3)

Aug. 14, 2025, 5:24 PM UTC

Whoop Inc., the maker of screen-less fitness bands, said it will not disable its blood-pressure tracking tool despite a request from the US Food and Drug Administration.

The FDA last month sent a warning letter to Whoop stating that the company’s Blood Pressure Insights feature, or BPI, which both measures blood pressure and provides related feedback, means that the Whoop is operating as a medical device.

The new Whoop MG — short for medical grade — doesn’t have such certification for blood pressure tracking despite intending to “help with the diagnosis, cure or treatment of a disease,” according to ...

Learn more about Bloomberg Law or Log In to keep reading:

Learn About Bloomberg Law

AI-powered legal analytics, workflow tools and premium legal & business news.

Already a subscriber?

Log in to keep reading or access research tools.